Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sarah Caroline Gomes de Lima"'
Autor:
Dan Cappabianca, Madison Bugel, Sarah Caroline Gomes de Lima, Ross Schwartz, Krishanu Saha, Christian Capitini
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Daniela Silvestrini Fernandes, Cristiano Ceron Jayme, Flavia Sayuri Matsuo, Sarah Caroline Gomes de Lima, Daianne Maciely Carvalho Fantacini, Lucas Eduardo Botelho de Souza, Antonio Claudio Tedesco
A number of different metallic nanoparticles have been extensively investigated in recent years based on their diverse potential in biomedical and cancer applications, antibacterial activity, and chemical properties. Here, silver nitroprusside nanopa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79033a171e3f9b06b4531861179566f9
https://doi.org/10.21203/rs.3.rs-2113732/v1
https://doi.org/10.21203/rs.3.rs-2113732/v1
Autor:
Hellen Franciane Gonçalves Barbosa, Henrique Luis Piva, Flavia Sayuri Matsuo, Sarah Caroline Gomes de Lima, Lucas Eduardo Botelho de Souza, Mariana Kiomy Osako, Antonio Claudio Tedesco
Publikováno v:
International Journal of Biological Macromolecules. 242:124647
Autor:
Lucas Eduardo Botelho de Souza, H Brand, Roberta Maraninchi Silveira, Izadora Peter Furtado, Rafaela Rossetti, Laís de Castro Batista, Sarah Caroline Gomes de Lima, Dimas Tadeu Covas, Daianne Maciely Carvalho Fantacini
Publikováno v:
Critical reviews in immunology. 41(1)
The field of cell therapy is leading a paradigm shift in drug development. The recent convergence of several fields, including immunology, genetics, and synthetic biology, now allows for the introduction of artificial receptors and the design of enti
Autor:
Sarah Caroline Gomes de Lima, Elza Tiemi Sakamoto-Hojo, Ana P. Montaldi, Paulo R. D. V. Godoy, Danilo J. Xavier
Publikováno v:
Oncology reports. 44(5)
Information on the mechanisms that are associated with tumor resistance has the potential to provide the fundamental basis for novel therapeutic strategies. In glioblastoma (GBM), predictive biomarkers of cellular responses to temozolomide (TMZ) comb